Frontier Pharmaceutical Inc. – Trademark Portfolio
Entity Type: 03
Frontier Pharmaceutical Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include CIDERM, NAIL-IT, EARIGANT, WUZAWART, and DIOXICARE. The owner is based in Melville, NY.
10 Ponderosa Drive
Melville, NY 11747
Showing of trademarks Trademarks
Trademark Classifications
Frontier Pharmaceutical Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Frontier Pharmaceutical Inc. have?
Frontier Pharmaceutical Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned, 1 cancelled.
What trademark classes does Frontier Pharmaceutical Inc. file in?
Frontier Pharmaceutical Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Frontier Pharmaceutical Inc.'s most well-known trademarks?
Frontier Pharmaceutical Inc.'s registered trademark portfolio includes well-known marks such as CIDERM, NAIL-IT, EARIGANT, WUZAWART, and DIOXICARE. These are among 10 currently registered trademarks in the portfolio.
What is Frontier Pharmaceutical Inc.'s trademark registration success rate?
Frontier Pharmaceutical Inc. has a 83% trademark registration rate, with 10 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.